Colorado drug board sets first state pricing limit for Amgen’s Enbrel in 2027

Colorado became the first state to set a payment limit for a prescription drug last week, with its drug affordability board agreeing to a nearly 70% reduction off the list price for Amgen’s blockbuster rheumatoid …
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks